Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cyxone AB

CYXO
Current price
0.041 SEK +0.001 SEK (+2.53%)
Last closed 0.04 SEK
ISIN SE0007815428
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 14 902 744 SEK
Yield for 12 month -88.51 %
1Y
3Y
5Y
10Y
15Y
CYXO
21.11.2021 - 28.11.2021

Cyxone AB (publ), a clinical stage biotech company, develops disease modifying therapies for autoimmune and autoinflammatory diseases. Its product pipeline comprises Rabeximod, which is in phase II clinical development for the treatment of rheumatoid arthritis; and T20K for the treatment of multiple sclerosis and is in phase I trial. The company was founded in 2015 and is headquartered in Malmö, Sweden. Address: Hylle Boulevard 34, Malmö, Sweden, 215 32

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

42.7 SEK

P/E ratio

Dividend Yield

Current Year

+5 113 836 SEK

Last Year

+6 356 530 SEK

Current Quarter

Last Quarter

+1 131 438 SEK

Current Year

+2 593 666 SEK

Last Year

+4 130 399 SEK

Current Quarter

+364 566 SEK

Last Quarter

+2 262 885 SEK

Key Figures CYXO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -19 548 393 SEK
Operating Margin TTM -1231.69 %
PE Ratio
Return On Assets TTM -36.18 %
PEG Ratio
Return On Equity TTM -70.7 %
Wall Street Target Price 42.7 SEK
Revenue TTM 6 627 717 SEK
Book Value 0.12 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -20.3 %
Dividend Yield
Gross Profit TTM 6 356 529 SEK
Earnings per share -0.14 SEK
Diluted Eps TTM -0.14 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CYXO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CYXO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CYXO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 144750.216
Price Sales TTM 2.2485
Enterprise Value EBITDA -0.24
Price Book MRQ 0.5013

Financials CYXO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CYXO

For 52 weeks

0.037 SEK 0.38 SEK
50 Day MA 0.057 SEK
Shares Short Prior Month
200 Day MA 0.094 SEK
Short Ratio
Shares Short
Short Percent